Loading...
Bienvenue sur la collection HAL du laboratoire de BECCOH
Quelques conseils pour une publication "idéHALe"
• Pensez à respecter la signature institutionnelle
Université Paris-Saclay, UVSQ, BECCOH, 92104, Boulogne-Billancourt, France..
• Participez à l'accès ouvert
N'attendez pas : dès que votre article est en ligne, déposez dans Hal sa version acceptée pour publication et indiquez un embargo de 6 mois.
La loi pour une république numérique vous autorise en effet à partager cette version 6 mois après publications, quelque-soit l'éditeur
Plus d'informations Archives Ouverte : quid de mes droits d'auteurs ?
• Vous souhaitez disposer d'une page web référençant toutes vos publications ?
Créez vous en 5 minutes un idHal et un CVHAL
N'hésitez pas à nous contacter pour toutes questions,
nous serions ravis d'échanger avec vous hal.bib@uvsq.fr
nous serions ravis d'échanger avec vous hal.bib@uvsq.fr
Dernières Publications en accès ouvert dans Hal
-
Paul Takam Kamga, Marie Mayenga, Louise Sebane, Adrien Costantini, Catherine Julie, et al.. Colony stimulating factor-1 (CSF-1) signalling is predictive of response to immune checkpoint inhibitors in advanced non-small cell lung cancer. Lung Cancer, 2024, 188, pp.107447. ⟨10.1016/j.lungcan.2023.107447⟩. ⟨hal-04517531⟩
-
Robin Zagala, Nicolas Meyer, Philippe Saiag, Nora Kramkimel, Celeste Lebbe, et al.. Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network. Journal of the European Academy of Dermatology and Venereology, In press, ⟨10.1111/jdv.20155⟩. ⟨hal-04626767⟩
-
Alexander Stratigos, Claus Garbe, Clio Dessinioti, Celeste Lebbe, Alexander van Akkooi, et al.. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment–Update 2023. European Journal of Cancer, 2023, 193, pp.113252. ⟨10.1016/j.ejca.2023.113252⟩. ⟨inserm-04209605⟩
-
Alexander Stratigos, Claus Garbe, Clio Dessinioti, Celeste Lebbe, Alexander van Akkooi, et al.. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention–Update 2023. European Journal of Cancer, 2023, 193, pp.113251. ⟨10.1016/j.ejca.2023.113251⟩. ⟨inserm-04210036⟩
-
Julien Taïeb, Olivier Bouche, Thierry André, Karine Le Malicot, Pierre Laurent-Puig, et al.. Avelumab vs Standard Second-Line Chemotherapy in Patients with Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial. JAMA oncology, 2023, 9 (10), ⟨10.1001/jamaoncol.2023.2761⟩. ⟨hal-04322943⟩
Mots clés
Cutaneous squamous cell carcinoma
Assisted reproductive techniques
EGFR
Chemoresistance
2-chlorodeoxyadenosine
Abdominal pain
BRAF V600-mutation
Merkel cell carcinoma
Circulating cell-free DNA
Nivolumab
Prognostic
Targeted therapy
Resistance
Sonic Hedgehog
Radiotherapy
Surgical excision
Gastric bypass
AZD9291
Advanced
Crizotinib
AML
Colon cancer
Acute generalized exanthematous pustulosis
Anti-PD-1 antibody
Adjuvant
Anti-PD-1
Wnt
Biomarkers
BRAF V600E
Diagnosis
BRAFV600E
Adjuvant therapy
Anti-CTLA-4
Body mass index
Metastatic cSCC
Biomarker
Abscopal effect anti-PD-1 antibody melanoma nivolumab pembrolizumab radiotherapy
Biliopancreatic diversion
Immunomodulation
Molecular targeted therapies
Antibody-drug conjugate
Immunohistochemistry
Safety
Adapted physical activity molecular diagnosis oligometastatic disease pancreatic adenocarcinoma KRAS mutation
BRAFV600E mutation
Langerhans cell histiocytosis
Non-small cell lung cancer
Systemic therapy
Antineoplastic agents
Immunotherapy
Advanced melanoma
Anti-PD1 blockade
BRAFV600-mutant melanoma
Radiofrequency ablation
Immune checkpoint inhibitor
Treatment
Prevention
Histiocytosis
Osimertinib
ADN tumoral circulant
Anti-Tumor pharmacology
Anti-PD1
Dabrafenib
Cemiplimab
Abscopal effect
Follow-up
ALK
Prognosis
Invasive cutaneous squamous cell carcinoma
Melanoma
BRAF
Plasma
ACTH
Biomarkers Colonic neoplasms Machine learning Prognosis Tumour infiltrating lymphocytes
Anti-CTLA-4 anti-PD-1 elderly immune checkpoint inhibitors melanoma nonagenarian octogenarian
Survival
ALK rearrangement
Circulating tumor DNA
Locally advanced
Chemotherapy
Abscopal effect colorectal cancer intratumoral immunotherapy liver metastases radiofrequency
Cancer
TNM classification
Adjuvant FOLFOX
Adverse events
Lung adenocarcinoma
Cancer bronchique non à petites cellules
Allelic imbalance
Mesenchymal stromal cells
Colorectal cancer
Polyomavirus
Bariatric surgery
Colorectal carcinoma
Trametinib
Bisphosphonates
Metastatic
Beta-catenin
Staging
Children
Androgen insensitivity